2024-04-29 17:37 | CC:ENBI | Entheon Biomedical Corp (2) | 0.16 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-04-29 17:24 | CC:ENBI | Entheon Biomedical Corp (2) | 0.16 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-04-19 00:56 | CC:ENBI | Entheon Biomedical Corp (2) | 0.155 | News Release200 | Entheon investor Canal Front acquires 900,000 shares |
2024-04-18 17:16 | CC:ENBI | Entheon Biomedical Corp (2) | 0.155 | News Release200 | Entheon Biomedical closes $147,500 private placement |
2024-04-11 11:48 | CC:ENBI | Entheon Biomedical Corp (2) | 0.12 | News Release200 | Entheon Biomedical arranges $147,500 private placement |
2024-03-25 21:26 | CC:ENBI | Entheon Biomedical Corp (2) | 0.11 | SEDAR MD & A815 | SEDAR MD & A |
2024-03-25 21:13 | CC:ENBI | Entheon Biomedical Corp (2) | 0.11 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-02-28 16:52 | CC:ENBI | Entheon Biomedical Corp (1) | 0.01 | Rollback291 | Entheon Biomedical 1:10 rollback |
2024-02-27 16:11 | CC:ENBI | Entheon Biomedical Corp | 0.01 | News Release200 | Entheon to roll back shares 1:10 March 1 |
2024-02-21 16:37 | CC:ENBI | Entheon Biomedical Corp | 0.01 | News Release200 | Entheon Biomedical arranges 1:10 share rollback |
2023-10-25 19:00 | CC:ENBI | Entheon Biomedical Corp | 0.01 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-10-25 19:00 | CC:ENBI | Entheon Biomedical Corp | 0.01 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-07-31 16:31 | CC:ENBI | Entheon Biomedical Corp | 0.025 | News Release200 | Entheon terminates chief science officer Hegle |
2023-07-26 18:03 | CC:ENBI | Entheon Biomedical Corp | 0.025 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |